img

Global Kyphosis Therapy Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Kyphosis Therapy Market Research Report 2024

Kyphoscoliosis is a medical condition characterized by abnormal curvature of the spine in both the sagittal and coronal planes. The condition can range from mild to severe and can be caused by various factors, including congenital abnormalities, neuromuscular disorders, or idiopathic causes.
According to MRAResearch’s new survey, global Kyphosis Therapy market is projected to reach US$ 3732 million in 2033, increasing from US$ 2887 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Kyphosis Therapy market research.
The kyphosis therapy market is driven by the increasing prevalence of kyphosis and the growing demand for effective treatment options. Kyphosis is a spinal disorder characterized by an excessive curvature of the upper back, leading to a hunched or rounded posture. The rise in risk factors such as aging, osteoporosis, and poor posture contributes to market growth. The development of non-surgical and surgical treatment options, such as physical therapy, bracing, and corrective surgeries, has improved patient outcomes and provided a range of therapeutic choices. However, the market also faces challenges, including the variability of kyphosis severity and underlying causes, which require personalized treatment approaches. Additionally, the potential for complications and the need for patient compliance can pose obstacles for successful kyphosis therapy. To succeed, companies must focus on research and development to offer innovative and patient-friendly therapeutic options, collaborate with healthcare providers to improve disease management, and address the challenges to meet the increasing demand for effective kyphosis therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Kyphosis Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Competition Deep Dive
Aurobindo Pharma
B. Braun
Integra LifeSciences
Johnson and Johnson
Medtronic
MicroPort Scientific
Orthofix
Perrigo
Stryker Corporation
Teva
Segment by Type
Medications
Surgery and Bracing

Segment by Application


Hospital
Clinics
Ambulatory Surgical Centres
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Kyphosis Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kyphosis Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Medications
1.2.3 Surgery and Bracing
1.3 Market by Application
1.3.1 Global Kyphosis Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centres
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kyphosis Therapy Market Perspective (2018-2033)
2.2 Kyphosis Therapy Growth Trends by Region
2.2.1 Global Kyphosis Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Kyphosis Therapy Historic Market Size by Region (2018-2023)
2.2.3 Kyphosis Therapy Forecasted Market Size by Region (2024-2033)
2.3 Kyphosis Therapy Market Dynamics
2.3.1 Kyphosis Therapy Industry Trends
2.3.2 Kyphosis Therapy Market Drivers
2.3.3 Kyphosis Therapy Market Challenges
2.3.4 Kyphosis Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kyphosis Therapy Players by Revenue
3.1.1 Global Top Kyphosis Therapy Players by Revenue (2018-2023)
3.1.2 Global Kyphosis Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Kyphosis Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Kyphosis Therapy Revenue
3.4 Global Kyphosis Therapy Market Concentration Ratio
3.4.1 Global Kyphosis Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kyphosis Therapy Revenue in 2022
3.5 Kyphosis Therapy Key Players Head office and Area Served
3.6 Key Players Kyphosis Therapy Product Solution and Service
3.7 Date of Enter into Kyphosis Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kyphosis Therapy Breakdown Data by Type
4.1 Global Kyphosis Therapy Historic Market Size by Type (2018-2023)
4.2 Global Kyphosis Therapy Forecasted Market Size by Type (2024-2033)
5 Kyphosis Therapy Breakdown Data by Application
5.1 Global Kyphosis Therapy Historic Market Size by Application (2018-2023)
5.2 Global Kyphosis Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Kyphosis Therapy Market Size (2018-2033)
6.2 North America Kyphosis Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Kyphosis Therapy Market Size by Country (2018-2023)
6.4 North America Kyphosis Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kyphosis Therapy Market Size (2018-2033)
7.2 Europe Kyphosis Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Kyphosis Therapy Market Size by Country (2018-2023)
7.4 Europe Kyphosis Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kyphosis Therapy Market Size (2018-2033)
8.2 Asia-Pacific Kyphosis Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Kyphosis Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Kyphosis Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Kyphosis Therapy Market Size (2018-2033)
9.2 Latin America Kyphosis Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Kyphosis Therapy Market Size by Country (2018-2023)
9.4 Latin America Kyphosis Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kyphosis Therapy Market Size (2018-2033)
10.2 Middle East & Africa Kyphosis Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Kyphosis Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Kyphosis Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Competition Deep Dive
11.1.1 Competition Deep Dive Company Detail
11.1.2 Competition Deep Dive Business Overview
11.1.3 Competition Deep Dive Kyphosis Therapy Introduction
11.1.4 Competition Deep Dive Revenue in Kyphosis Therapy Business (2018-2023)
11.1.5 Competition Deep Dive Recent Development
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Company Detail
11.2.2 Aurobindo Pharma Business Overview
11.2.3 Aurobindo Pharma Kyphosis Therapy Introduction
11.2.4 Aurobindo Pharma Revenue in Kyphosis Therapy Business (2018-2023)
11.2.5 Aurobindo Pharma Recent Development
11.3 B. Braun
11.3.1 B. Braun Company Detail
11.3.2 B. Braun Business Overview
11.3.3 B. Braun Kyphosis Therapy Introduction
11.3.4 B. Braun Revenue in Kyphosis Therapy Business (2018-2023)
11.3.5 B. Braun Recent Development
11.4 Integra LifeSciences
11.4.1 Integra LifeSciences Company Detail
11.4.2 Integra LifeSciences Business Overview
11.4.3 Integra LifeSciences Kyphosis Therapy Introduction
11.4.4 Integra LifeSciences Revenue in Kyphosis Therapy Business (2018-2023)
11.4.5 Integra LifeSciences Recent Development
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Company Detail
11.5.2 Johnson and Johnson Business Overview
11.5.3 Johnson and Johnson Kyphosis Therapy Introduction
11.5.4 Johnson and Johnson Revenue in Kyphosis Therapy Business (2018-2023)
11.5.5 Johnson and Johnson Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Kyphosis Therapy Introduction
11.6.4 Medtronic Revenue in Kyphosis Therapy Business (2018-2023)
11.6.5 Medtronic Recent Development
11.7 MicroPort Scientific
11.7.1 MicroPort Scientific Company Detail
11.7.2 MicroPort Scientific Business Overview
11.7.3 MicroPort Scientific Kyphosis Therapy Introduction
11.7.4 MicroPort Scientific Revenue in Kyphosis Therapy Business (2018-2023)
11.7.5 MicroPort Scientific Recent Development
11.8 Orthofix
11.8.1 Orthofix Company Detail
11.8.2 Orthofix Business Overview
11.8.3 Orthofix Kyphosis Therapy Introduction
11.8.4 Orthofix Revenue in Kyphosis Therapy Business (2018-2023)
11.8.5 Orthofix Recent Development
11.9 Perrigo
11.9.1 Perrigo Company Detail
11.9.2 Perrigo Business Overview
11.9.3 Perrigo Kyphosis Therapy Introduction
11.9.4 Perrigo Revenue in Kyphosis Therapy Business (2018-2023)
11.9.5 Perrigo Recent Development
11.10 Stryker Corporation
11.10.1 Stryker Corporation Company Detail
11.10.2 Stryker Corporation Business Overview
11.10.3 Stryker Corporation Kyphosis Therapy Introduction
11.10.4 Stryker Corporation Revenue in Kyphosis Therapy Business (2018-2023)
11.10.5 Stryker Corporation Recent Development
11.11 Teva
11.11.1 Teva Company Detail
11.11.2 Teva Business Overview
11.11.3 Teva Kyphosis Therapy Introduction
11.11.4 Teva Revenue in Kyphosis Therapy Business (2018-2023)
11.11.5 Teva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Kyphosis Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Medications
Table 3. Key Players of Surgery and Bracing
Table 4. Global Kyphosis Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Kyphosis Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Kyphosis Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Kyphosis Therapy Market Share by Region (2018-2023)
Table 8. Global Kyphosis Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Kyphosis Therapy Market Share by Region (2024-2033)
Table 10. Kyphosis Therapy Market Trends
Table 11. Kyphosis Therapy Market Drivers
Table 12. Kyphosis Therapy Market Challenges
Table 13. Kyphosis Therapy Market Restraints
Table 14. Global Kyphosis Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Kyphosis Therapy Market Share by Players (2018-2023)
Table 16. Global Top Kyphosis Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kyphosis Therapy as of 2022)
Table 17. Ranking of Global Top Kyphosis Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Kyphosis Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Kyphosis Therapy Product Solution and Service
Table 21. Date of Enter into Kyphosis Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Kyphosis Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Kyphosis Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Kyphosis Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Kyphosis Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Kyphosis Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Kyphosis Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Kyphosis Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Kyphosis Therapy Revenue Market Share by Application (2024-2033)
Table 31. North America Kyphosis Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Kyphosis Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Kyphosis Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Kyphosis Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Kyphosis Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Kyphosis Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Kyphosis Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Kyphosis Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Kyphosis Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Kyphosis Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Kyphosis Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Kyphosis Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Kyphosis Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Kyphosis Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Kyphosis Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Competition Deep Dive Company Detail
Table 47. Competition Deep Dive Business Overview
Table 48. Competition Deep Dive Kyphosis Therapy Product
Table 49. Competition Deep Dive Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 50. Competition Deep Dive Recent Development
Table 51. Aurobindo Pharma Company Detail
Table 52. Aurobindo Pharma Business Overview
Table 53. Aurobindo Pharma Kyphosis Therapy Product
Table 54. Aurobindo Pharma Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 55. Aurobindo Pharma Recent Development
Table 56. B. Braun Company Detail
Table 57. B. Braun Business Overview
Table 58. B. Braun Kyphosis Therapy Product
Table 59. B. Braun Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 60. B. Braun Recent Development
Table 61. Integra LifeSciences Company Detail
Table 62. Integra LifeSciences Business Overview
Table 63. Integra LifeSciences Kyphosis Therapy Product
Table 64. Integra LifeSciences Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 65. Integra LifeSciences Recent Development
Table 66. Johnson and Johnson Company Detail
Table 67. Johnson and Johnson Business Overview
Table 68. Johnson and Johnson Kyphosis Therapy Product
Table 69. Johnson and Johnson Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 70. Johnson and Johnson Recent Development
Table 71. Medtronic Company Detail
Table 72. Medtronic Business Overview
Table 73. Medtronic Kyphosis Therapy Product
Table 74. Medtronic Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 75. Medtronic Recent Development
Table 76. MicroPort Scientific Company Detail
Table 77. MicroPort Scientific Business Overview
Table 78. MicroPort Scientific Kyphosis Therapy Product
Table 79. MicroPort Scientific Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 80. MicroPort Scientific Recent Development
Table 81. Orthofix Company Detail
Table 82. Orthofix Business Overview
Table 83. Orthofix Kyphosis Therapy Product
Table 84. Orthofix Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 85. Orthofix Recent Development
Table 86. Perrigo Company Detail
Table 87. Perrigo Business Overview
Table 88. Perrigo Kyphosis Therapy Product
Table 89. Perrigo Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 90. Perrigo Recent Development
Table 91. Stryker Corporation Company Detail
Table 92. Stryker Corporation Business Overview
Table 93. Stryker Corporation Kyphosis Therapy Product
Table 94. Stryker Corporation Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 95. Stryker Corporation Recent Development
Table 96. Teva Company Detail
Table 97. Teva Business Overview
Table 98. Teva Kyphosis Therapy Product
Table 99. Teva Revenue in Kyphosis Therapy Business (2018-2023) & (US$ Million)
Table 100. Teva Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kyphosis Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Kyphosis Therapy Market Share by Type: 2022 VS 2033
Figure 3. Medications Features
Figure 4. Surgery and Bracing Features
Figure 5. Global Kyphosis Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Kyphosis Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centres Case Studies
Figure 10. Kyphosis Therapy Report Years Considered
Figure 11. Global Kyphosis Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Kyphosis Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Kyphosis Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Kyphosis Therapy Market Share by Players in 2022
Figure 15. Global Top Kyphosis Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kyphosis Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Kyphosis Therapy Revenue in 2022
Figure 17. North America Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Kyphosis Therapy Market Share by Country (2018-2033)
Figure 19. United States Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Kyphosis Therapy Market Share by Country (2018-2033)
Figure 23. Germany Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Kyphosis Therapy Market Share by Region (2018-2033)
Figure 31. China Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Kyphosis Therapy Market Share by Country (2018-2033)
Figure 39. Mexico Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Kyphosis Therapy Market Share by Country (2018-2033)
Figure 43. Turkey Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Kyphosis Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Competition Deep Dive Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 46. Aurobindo Pharma Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 47. B. Braun Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 48. Integra LifeSciences Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 49. Johnson and Johnson Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 50. Medtronic Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 51. MicroPort Scientific Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 52. Orthofix Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 53. Perrigo Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 54. Stryker Corporation Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 55. Teva Revenue Growth Rate in Kyphosis Therapy Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed